F

SEC EDGAR - Form 4 insider activity

Fennec Pharmaceuticals Inc. $FENC

Tracked equity - 10 filings indexed by Nortis

Nortis signal thesis

Cluster activity detected. Review whether the filings are open-market trades or routine compensation events.

0

OM buys - 90d

0

OM sells - 90d

10

Routine filings

10

Cluster filings

$21.8K

Largest trade

15/100

Avg signal score

Filing tape

Recent filings

Last 30d: 10
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-13
SSOfficer

Sayad Pierre Sargis - Chief Medical Officer - $21.3K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-13
HSCEO

Hackman Jeffrey S. - Director, Chief Executive Officer - $12.3K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-13
ELOfficer

Evans Terry L - Chief Commercial Officer - $12.9K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-13
CMOfficer

Cioffi Christiana Marie - Chief Strategy Officer - $21.8K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-13
ARCFO

Andrade Robert - CHIEF FINANCIAL OFFICER - $21.3K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-01
SSOfficer

Sayad Pierre Sargis - Chief Medical Officer - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-01
ELOfficer

Evans Terry L - Chief Commercial Officer - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-01
HSCEO

Hackman Jeffrey S. - Director, Chief Executive Officer - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-01
CMOfficer

Cioffi Christiana Marie - Chief Strategy Officer - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-01
ARCFO

Andrade Robert - CHIEF FINANCIAL OFFICER - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing